Reference drugs for triple combination test drug in Russia [Design Issues]

posted by PharmCat  – Russia, 2019-11-16 18:22 (1167 d 17:31 ago) – Posting: # 20812
Views: 4,493

❝ Generic companies did develop almost all attractive double combinations for cardiovasulcar diseases and were trying to expand to triple combinations.


And all this at the moment is a offense against the law.

Complete thread:

UA Flag
Activity
 Admin contact
22,477 posts in 4,708 threads, 1,603 registered users;
14 visitors (0 registered, 14 guests [including 5 identified bots]).
Forum time: 11:53 CET (Europe/Vienna)

In these matters the only certainty is
that nothing is certain.    Pliny the Elder

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5